Atrial Fibrillation Trial, Recruiting NCT07601763 Sponsor: China National Center for Cardiovascular Diseases Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07601763
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have atrial fibrillation (an irregular heartbeat condition) and are planning to have a catheter ablation procedure
  • People who are 18 years of age or older
  • People who are able to understand and sign a consent form agreeing to take part

Who may not be able to join:

  • People for whom catheter ablation is considered medically unsafe — for example, those who have a blood clot in the heart or severe heart failure (confirm with trial site)
  • People who have had a catheter ablation procedure before
  • People who have had a heart attack, or any heart-related procedure or surgery, within the past 3 months
  • People who have had a stroke or a brief stroke-like episode (sometimes called a "mini-stroke") within the past 6 months
  • People who have an allergy to iodine-based contrast dyes (a type of dye used in medical imaging)
  • People who are currently taking part in another clinical trial involving a drug or medical device
  • People who are pregnant, breastfeeding, or planning to become pregnant in the near future
  • People who are currently dealing with an active infection
  • People whose atrial fibrillation is caused by another underlying heart condition, such as rheumatic heart disease or a thickened heart muscle condition (hypertrophic cardiomyopathy)
  • People who do not wish to take part or who are not able to cooperate with completing the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010-88392405

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
30 November 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Recurrence of atrial fibrillation within 12 months after ablation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov